Seeing and seizing new opportunities: the specialist in venture capital and financing transactions.
Daniel Haymann specialises in corporate and commercial law. Thanks to his extensive business experience, he has a good sense for new markets and understands the requirements for market launch and scale-up strategies. As an interdisciplinary and hands-on advisor, his focus is on investments, venture capital and financing transactions as well as regulatory issues in the healthcare and consumer goods sectors.
He has been advising investors, start-ups, and vertically integrated companies along the value chain, including on regulatory matters relating to THC, CBD and other cannabinoids and psychedelic compounds, on GMP and GDP standards, foodstuff and cosmetics regulations as well as authorization procedures before Swissmedic, the Swiss Agency for Therapeutic Products.
Daniel is the co-founder and co-chair of the European offshoot of the International Cannabis Bar Association (INCBA Europe). In addition, as a dual Swiss-Israeli citizen, he focuses on supporting clients with ties to Israel and strengthening the corresponding business relationships and heads the MME Israel Desk.
Prior to his career as a lawyer, Daniel spent over 10 years as a commodities trader for multinational corporations in senior management positions.
| 2011 - 2013 | Hong Kong University of Science and Technology HKUST (MBA) |
| 2004 | University of Zurich (lic. iur.) |
German, English, French, Spanish, Hebrew
| since 2023 | Legal Counsel at MME |
| 2019 - 2023 | Lawyer in a leading law firm in Zurich |
| 2019 | Admission to the bar |
| 2014 - 2017 | Management positions in industry (mixed holding company and oil trading) |
| 2007 - 2014 | Management positions in leading commodity trading companies in Baar, Singapore and Hong Kong |
